CMS Presents a Videos for Caregivers Addressing Medication Issues
FDA Approves More Research Into Deep Brain Stimulation for Alzheimer’s

Alzheimer’s Drugs to be Compared Side by Side in New Trials

Researchers leading the Dominantly Inherited Alzheimer's Network (DIAN) recently announced that two pharmaceutical companies have agreed to donate investigational drugs to use in side by side trials in people who are destined by genetics to develop early-onset Alzheimer's disease. The companies have agreed to at least partially fund a five-year therapy trial, as well. 

Read more about Alzheimer's drug trial:

Purchase Minding Our Elders: Caregivers Share Their Personal Stories – paperback or ebook


Feed You can follow this conversation by subscribing to the comment feed for this post.

The comments to this entry are closed.